BenzingaAugust 5, 2026 at 12:39 PM NYlast month

Black Diamond Therapeutic Q2 EPS $(0.17) Beats $(0.19) Estimate

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 10.53 percent increase over losses of $(0.19) per

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Read at Source

Companies in This Story

BDTXBlack Diamond Therapeutics Inc2.12+ 0.95%

Companies in This Story

Related Stories